These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 19236099)

  • 1. AR inhibitors identified by high-throughput microscopy detection of conformational change and subcellular localization.
    Jones JO; An WF; Diamond MI
    ACS Chem Biol; 2009 Mar; 4(3):199-208. PubMed ID: 19236099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-parameter imaging assay identifies different stages of ligand-induced androgen receptor activation.
    van Royen ME; van de Wijngaart DJ; Cunha SM; Trapman J; Houtsmuller AB
    Cytometry A; 2013 Sep; 83(9):806-17. PubMed ID: 23585273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor.
    Georget V; Térouanne B; Nicolas JC; Sultan C
    Biochemistry; 2002 Oct; 41(39):11824-31. PubMed ID: 12269826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.
    Hua Y; Shun TY; Strock CJ; Johnston PA
    Assay Drug Dev Technol; 2014 Sep; 12(7):395-418. PubMed ID: 25181412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
    Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer.
    Singh P; Hallur G; Anchoori RK; Bakare O; Kageyama Y; Khan SR; Isaacs JT
    Prostate; 2008 Oct; 68(14):1570-81. PubMed ID: 18668523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells.
    Lu S; Wang A; Lu S; Dong Z
    Mol Cancer Ther; 2007 Jul; 6(7):2057-64. PubMed ID: 17620434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors.
    Helsen C; Nguyen TT; Lee XY; Eerlings R; Louros N; Schymkowitz J; Rousseau F; Claessens F; Voet A
    Mol Cancer Ther; 2022 Dec; 21(12):1823-1834. PubMed ID: 36218067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
    Whitaker HC; Hanrahan S; Totty N; Gamble SC; Waxman J; Cato AC; Hurst HC; Bevan CL
    Clin Cancer Res; 2004 Nov; 10(21):7392-401. PubMed ID: 15534116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "True" antiandrogens-selective non-ligand-binding pocket disruptors of androgen receptor-coactivator interactions: novel tools for prostate cancer.
    Caboni L; Kinsella GK; Blanco F; Fayne D; Jagoe WN; Carr M; Williams DC; Meegan MJ; Lloyd DG
    J Med Chem; 2012 Feb; 55(4):1635-44. PubMed ID: 22280402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide antagonist of the androgen receptor.
    Gao W
    Curr Pharm Des; 2010; 16(9):1106-13. PubMed ID: 20030610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays.
    Zhou W; Duan M; Fu W; Pang J; Tang Q; Sun H; Xu L; Chang S; Li D; Hou T
    Genomics Proteomics Bioinformatics; 2018 Dec; 16(6):416-427. PubMed ID: 30639122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic action of a synthetic androgen ligand mediated by chromatin remodeling in a human prostate cancer cell line.
    Sawada T; Kanemoto Y; Amano R; Hayakawa A; Kurokawa T; Mori J; Kato S
    Biochem Biophys Res Commun; 2022 Jul; 612():110-118. PubMed ID: 35523048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.
    Wilson VS; Bobseine K; Lambright CR; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic communication between androgen and coactivator: mutually induced conformational perturbations in androgen receptor ligand-binding domain.
    Xu X; Yang W; Wang X; Li Y; Wang Y; Ai C
    Proteins; 2011 Apr; 79(4):1154-71. PubMed ID: 21322031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel androgen receptor antagonists using structure- and ligand-based methods.
    Li H; Ren X; Leblanc E; Frewin K; Rennie PS; Cherkasov A
    J Chem Inf Model; 2013 Jan; 53(1):123-30. PubMed ID: 23278403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.
    Tyagi RK; Lavrovsky Y; Ahn SC; Song CS; Chatterjee B; Roy AK
    Mol Endocrinol; 2000 Aug; 14(8):1162-74. PubMed ID: 10935541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP.
    Warriar N; Pagé N; Koutsilieris M; Govindan MV
    Prostate; 1994 Apr; 24(4):176-86. PubMed ID: 8146066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
    Cherian MT; Wilson EM; Shapiro DJ
    J Biol Chem; 2012 Jul; 287(28):23368-80. PubMed ID: 22589544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.